J. Lau

Endocrinology, Diabetes and Metabolism · 2015–2019

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Lau trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Felix Kratz

Papers from J. Lau's perspective

Ordered by how strongly the researchers J. Lau trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. (Journal of Molecular Biology)
  2. Impact of albumin on drug delivery--new applications on the horizon. (Journal of Controlled Release)
  3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. (New England Journal of Medicine)
  4. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. (The Lancet)
  5. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection (Nature Medicine)
  6. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. (Journal of Clinical Investigation)
  7. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. (Diabetes)
  8. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. (The Lancet Diabetes and Endocrinology)
  9. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. (The Lancet Diabetes and Endocrinology)
  10. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction (Journal of the American Medical Association (JAMA))

Their papers